J. Marruecos

454 total citations
21 papers, 288 citations indexed

About

J. Marruecos is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, J. Marruecos has authored 21 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 8 papers in Otorhinolaryngology. Recurrent topics in J. Marruecos's work include Head and Neck Cancer Studies (8 papers), Brain Metastases and Treatment (6 papers) and Lung Cancer Research Studies (4 papers). J. Marruecos is often cited by papers focused on Head and Neck Cancer Studies (8 papers), Brain Metastases and Treatment (6 papers) and Lung Cancer Research Studies (4 papers). J. Marruecos collaborates with scholars based in Spain, United States and France. J. Marruecos's co-authors include C. Conill, E. Verger, Juan Berenguer, R. Vilella, Albert Biete, Josep Domingo‐Domenech, Rut Porta, Izaskun Valduvieco, Á. Izquierdo and Joaquim Bosch‐Barrera and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Annals of Oncology.

In The Last Decade

J. Marruecos

19 papers receiving 278 citations

Peers

Countries citing papers authored by J. Marruecos

Since Specialization

Citations

This map shows the geographic impact of J. Marruecos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Marruecos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Marruecos more than expected).

Fields of papers citing papers by J. Marruecos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Marruecos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Marruecos. The network helps show where J. Marruecos may publish in the future.

Co-authorship network of co-authors of J. Marruecos

This figure shows the co-authorship network connecting the top 25 collaborators of J. Marruecos. A scholar is included among the top collaborators of J. Marruecos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Marruecos. J. Marruecos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	A population-based study of incidence trends of head and neck epithelial cancers in northeastern Spain, 1994–2018	Clinical & Translational Oncology	Jordi Rubió‐Casadevall, Carlota Calvo et al.	0
2	TTCC-2022-01: Niraparib and dostarlimab in locally-advanced head and neck squamous cell carcinoma treated with (chemo) radiotherapy (RADIAN).	Journal of Clinical Oncology	Virginia Arrazubi, Neus Basté et al.	2
3	Melatonin Targets Metabolism in Head and Neck Cancer Cells by Regulating Mitochondrial Structure and Function	Antioxidants	Ana Guerra‐Librero, Beatriz I. Fernández-Gil et al.	32
4	Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment	Clinical & Translational Oncology	Alicia Lozano, J. Marruecos et al.	28
5	Population-based risk assessment of second primary cancers following a first head and neck cancer: patterns of association and difficulties of its analysis	Clinical & Translational Oncology	Jordi Rubió‐Casadevall, Jaume Galcerán et al.	3
6	PD-029 Phase II trial: melatonin oral gel for prevention of mucositis in oropharynx and oral cavity tumors	Radiotherapy and Oncology	J. Marruecos, Jordi Rubió‐Casadevall et al.	1
7	Dosimetric impact of Acuros XB dose-to-water and dose-to-medium reporting modes on VMAT planning for head and neck cancer	Physica Medica	J. Marruecos, María Buxó et al.	20
8	Phase II trial of high-dose melatonin oral gel for the prevention and treatment of oral mucositis in H&N cancer patients undergoing chemoradiation (MUCOMEL).	Journal of Clinical Oncology	Alicia Lozano, J. Marruecos et al.	9
9	Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1)	Oral Oncology	M. Mañós, J. Giralt et al.	22
10	MGMT methylated (Met) patients (p) with glioblastoma (GBM) have a better prognosis with an earlier response (ER) than those who have a late response or pseudoprogression (LR/PsP). Results of the Gliocat study	Annals of Oncology	Anna Estival, Estela Pineda et al.	1
11	Cetuximab as treatment for head and neck cancer patients with a previous liver transplant: report of two cases	Journal of Chemotherapy	Jordi Rubió‐Casadevall, Maria Saigí et al.	0
12	Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin	Oncotarget	Joaquim Bosch‐Barrera, J. Marruecos et al.	39
13	Diagnostic efficacy of bone scintigraphy, magnetic resonance imaging, and positron emission tomography in bone metastases of myxoid liposarcoma	Journal of Magnetic Resonance Imaging	C. Conill, Xavier Setoaín et al.	21
14	Occipital condyle syndrome secondary to bone metastases from rectal cancer	Clinical & Translational Oncology	J. Marruecos, C. Conill et al.	6
15	Toxicity of combined treatment of adjuvant irradiation and interferon α2b in high-risk melanoma patients	Melanoma Research	C. Conill, S. Jorcano et al.	18
16	Low dose rate brachytherapy in lip carcinoma	Clinical & Translational Oncology	C. Conill, E. Verger et al.	25
17	Clinical outcome in patients with intramedullary spinal cord metastases from lung cancer	Clinical & Translational Oncology	C. Conill, J. Marruecos et al.	18
18	Clinical outcome after surgical resection of lung metastases from melanoma	Clinical & Translational Oncology	J. Marruecos, Josep Domingo‐Domenech et al.	7
19	Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases	Clinical & Translational Oncology	C. Conill, Juan Berenguer et al.	21
20	Spanish patterns of care for 3D radiotherapy in non–small-cell lung cancer	International Journal of Radiation OncologyBiologyPhysics	Francesc Casas, A. Sánchez‐Reyes et al.	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact